Researchers led by Professor Jonathan Valabhji from Imperial’s Department of Metabolism Digestion and Reproduction have investigated the potential of incorporating a 12-lead ECG into routine care for patients with diabetic foot ulcers to reduce mortality rates. A real-world implementation pilot conducted across ten multidisciplinary diabetic foot services in England from July 2014 to December 2017 analyzed mortality rates at 2- and 5-year intervals. While overall mortality rates were not significantly reduced, those who received an ECG showed potential mortality benefits at the 5-year mark. Challenges in implementation, such as low ECG uptake, were noted, but the study suggests that effective integration of the 12-lead ECG into care pathways could improve patient outcomes. Professor Valabhji emphasized the importance of addressing high mortality rates associated with diabetic foot ulcers and highlighted the potential of incorporating ECGs into routine care pathways to save lives.
3 Likes
Wow, this study sounds promising! It’s fascinating to see how incorporating a simple tool like a 12-lead ECG could potentially improve outcomes for patients with diabetic foot ulcers. Addressing mortality rates in this population is crucial, and finding innovative ways to integrate such tools into routine care pathways could make a big difference.
2 Likes
It’s fascinating to see how medical research is exploring innovative ways to improve patient outcomes. I’m curious, though, what do you think are some of the main challenges in integrating 12-lead ECGs into routine care pathways, and how do you think those challenges could be addressed to maximise the potential benefits for patients?
1 Like